The fruitful partnership between CILcare and its US partner has been highlighted in the Business Wire release. The release communicates the appointment of Dr. Wahid Awad as Chief Business Officer and his election to CILcare’s Board of Directors. Previously, Dr. Awad served as CILcare’s Director of Business Strategy and Alliances.
“Dr. Awad is most deserving of this expanded responsibility at CILcare. We value our partnership with CILcare and look forward to continuing to assist our sponsors in developing and testing pharmaceutical and implantable therapies related to hearing disorders.” said Michael Naimark, Director of Business Development at CBSET.